Spred-2 Suppresses Aorta-Gonad-Mesonephros Hematopoiesis by Inhibiting MAP Kinase Activation by Nobuhisa, Ikuo et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
 
J. Exp. Med. 
 

 
 The Rockefeller University Press • 0022-1007/2004/03/737/6 $8.00
Volume 199, Number 5, March 1, 2004 737–742
http://www.jem.org/cgi/doi/10.1084/jem.20030830
 
Brief Deﬁnitive Report
 
737
 
Spred-2 Suppresses Aorta-Gonad-Mesonephros 
Hematopoiesis by Inhibiting MAP Kinase Activation
 
Ikuo Nobuhisa,
 
1 
 
Reiko Kato,
 
2 
 
Hirofumi Inoue,
 
1 
 
Makiko Takizawa,
 
1
 
Keisuke Okita,
 
1 
 
Akihiko Yoshimura,
 
2 
 
and Tetsuya Taga
 
1
 
1
 
Department of Cell Fate Modulation, Institute of Molecular Embryology and Genetics, Kumamoto University, 
Kumamoto 860-0811, Japan
 
2
 
Division of Molecular and Cellular Immunology, Medical Institute of Bioregulation, Kyushu University, 
Fukuoka 812-8582, Japan
 
Abstract
 
In midgestation mouse embryos, the aorta-gonad-mesonephros (AGM) region generates hemato-
poietic stem cells and definitive hematopoiesis is regulated by cell–cell interaction and signaling
molecules. We showed that a Ras/mitogen-activated protein (MAP) kinase signaling-specific
inhibitor and a dominant negative mutant Ras blocked the production of CD45
 
  
 
hematopoietic
cells in embryonic day 11.5 AGM culture, indicating an essential role for the MAP kinase path-
way in AGM hematopoiesis. Overexpression of the Ras/MAP kinase pathway regulator,
Spred-2, in the AGM culture significantly reduced the number of CD45
 
  
 
cells. In contrast,
production of CD45
 
  
 
cells from the AGM region of Spred-2–null mice was up-regulated as
compared with wild-type littermates. Furthermore, Spred-2–deficient mice exhibited elevated
hematopoietic colony formation from vascular endothelial-cadherin
 
  
 
cells. These data indicate
that Spred-2 functions as a negative regulator of AGM hematopoiesis by inhibiting hematopoietic
cytokine signaling.
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Introduction
 
Hematopoietic cells are derived from multipotent progenitors,
hematopoietic stem cells (HSCs). During embryogenesis,
development of the hematopoietic system is dependent on
a hierarchical mechanism, which is influenced by environ-
mental niches, having contacts with stromal cells and extra-
cellular signals including cytokines, thereby inducing ex-
pression of unique transcription factors via an intracellular
signaling pathway. In the midgestation mouse embryo, defini-
tive hematopoiesis occurs in the aorta-gonad-mesonephros
(AGM) region, which contains a population that is able to
repopulate irradiated mice upon direct transplantation (1,
2). Within the AGM region, the first HSCs are generated
in the dorsal aorta (3). More recently, endothelial cells that
overlap with expression of HSCs markers (Sca-1 and c-Kit)
in midgestation mouse aorta have long-term reconstitution
activities (3–5). However, intracellular signals that regulate
this hematopoiesis have not been clarified.
Recently, we cloned a family of novel membrane-
bound molecules, Spred-1, Spred-2, and Spred-3 (6, 7),
which are related to Sprouty family proteins that act as
negative regulators during development (8, 9). Spred-1,
Spred-2, and Spred-3 inhibit the Ras/mitogen-activated
protein (MAP) kinase cascade mediated by fibroblast
growth factor receptor and epidermal growth factor receptor,
by binding to Ras and consequently inhibiting phosphory-
lation of Raf. Spred proteins have a negative effect on extra-
cellular signal–regulated kinase (Erk)-dependent differentiation
in PC12 pheochromocytoma cells and C2C12 myoblastic
cells (7). The physiological functions of Spred proteins,
however, remain to be elucidated. In this study, we dem-
onstrated the importance of Spred-2 for hematopoiesis in
the midgestation mouse embryo and, in part, in adult
bone marrow.
 
Materials and Methods
 
Spred-2–null Mice.
 
A targeting vector was constructed to
delete exon 6 of Spred-2–encoding KBD and SPR domains.
Targeting of embryonic stem cells and the generation of chimeric
mice were performed according to a previously published procedure
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(10). Detailed analysis of embryonic stem clones and Spred-2–
null mice will be published elsewhere.
 
AGM Cultures and Semisolid Colony-forming Assay.
 
AGM cul-
tures and semisolid colony-forming assay were performed as pre-
viously described (11).
 
RT-PCR.
 
5 
 
 
 
g total RNA isolated from E11.5 AGM was
reverse transcribed with Superscript II (GIBCO BRL). PCRs
were performed using rTaq (Takara Biotechnology Inc.) with the
following settings: 95
 
 
 
C for 3 min, 26 cycles at 95
 
 
 
C for 10 s,
55
 
 
 
C for 10 s, and 72
 
 
 
C for 1 min. The primer sets used were as
follows: 5
 
 
 
-TGTGAGCACCGGAAGATTTATACC-3
 
 
 
, 5
 
 
 
-
CGCGGCGGCTTTGTGCTT-3
 
  
 
(for Spred-2); 5
 
 
 
-AGCACT-
GATTATATTCCTGG-3
 
 
 
, 5
 
 
 
-TGCTTGGCCAGTATTCT-
GCG-3
 
  
 
(for CD45); 5
 
 
 
-ACCACCCGATACCCACCTAT-3
 
 
 
,
5
 
 
 
-GCCATGGCAGTCACCATGCT-3
 
  
 
(for GATA-2); and
5
 
 
 
-ACCACAGTCCATGCCATCAC-3
 
 
 
, 5
 
 
 
-TCCACCACCC-
TGTTGCTGTA-3
 
  
 
(for G3PDH).
 
Retrovirus Infection of Cells.
 
We prepared mutant proteins of
Spred-2 (see Fig. 2 B): 
 
 
 
N, with the NH
 
2
 
-terminal EVH-1 do-
main (residues 1–139) deletion; 
 
 
 
C, with the COOH-terminal
SPR domain (residues 289–410) deletion; and 
 
 
 
KBD, with the
c-Kit–binding domain (residues 197–287) deletion. Production
of retroviruses and infection of AGM cultures were performed as
previously described (11).
 
Flow Cytometry.
 
The nonadherent cells, which were recov-
ered from the AGM culture, were stained with PE-conjugated rat
anti–mouse CD45 (30-F11; Becton Dickinson) for 30 min on
ice. After washing, stained cells were analyzed by FACSCalibur™
(Becton Dickinson). The percentage of CD45
 
  
 
cells in the virus-
infected green fluorescent protein (GFP)
 
  
 
cells was determined.
 
Cell Sorting and Coculture with OP9 Stroma Cells.
 
Nonadher-
ent cells derived from the mock-infected AGM culture were
stained with PE-conjugated anti–mouse CD45 (30-F11) and al-
lophycocyanin-conjugated anti–mouse c-Kit (2B8; Becton Dick-
inson). GFP
 
  
 
CD45
 
  
 
c-Kit
 
 
 
, GFP
 
  
 
CD45
 
low 
 
c-Kit
 
low/
 
 
 
, and
GFP
 
  
 
CD45
 
  
 
c-Kit
 
  
 
cells were sorted by FACS Vantage™ (Bec-
ton Dickinson). Each of sorted cells (2 
 
  
 
10
 
3
 
) in each population
were seeded on OP9 stromal cells in DMEM supplemented with
10% (vol/vol) fetal calf serum, 100 ng/ml IL-3, 100 ng/ml stem
cell factor (SCF), and 4 U/ml erythropoietin (EPO).
Spred-2
 
 
 
/
 
  
 
and Spred-2
 
 
 
/
 
  
 
E10.5 embryonic trunk lower than
the heart was incubated in dispase II (Roche) at 37
 
 
 
C for 20 min.
After washing in PBS, cells were treated with cell dissociation
buffer (Invitrogen) at 37
 
 
 
C for 20 min. Dissociated cells were
stained with anti–mouse vascular endothelial-cadherin (VE-cad;
11D4.1; Becton Dickinson). 2 
 
  
 
10
 
3 
 
sorted VE-cad
 
  
 
cells were
seeded on OP9 stromal cells in the medium as described above.
After 3 d, cobble stone area–forming cells were counted.
 
Immunoblotting and Coimmunoprecipitation Analyses.
 
2 
 
  
 
10
 
6
 
Plat-E cells (12) were transfected with expression constructs using a
Trans-IT 293 (Mirus). On the next day, cells were starved for 16 h
and then treated with 100 ng/ml SCF for 5 min. Cell lysates were
immunoprecipitated with anti-GFP antibody (Medical & Biological
Laboratories, Co.). Immunoprecipitates or cell lysates were separated
by SDS-PAGE and immunoblotted with anti–phospho-Erk1/2 an-
tibody (E10; Cell Signaling Technology), anti-Erk2 antibody (sc-
145; Santa Cruz Biotechnology, Inc.), anti–c-Kit (M-14; Santa Cruz
Biotechnology, Inc.), and anti-Flag (M2; Sigma-Aldrich) antibody.
 
Pharmacological Reagents.
 
AGM cells cultured for 2 d were
treated with 0, 1, 3, or 10 
 
 
 
M U0126 (Cell Signaling Technol-
ogy) or SB203538 (Calbiochem). After 8 d of treatment, the
nonadherent cells were counted and analyzed for determination
of the percentage of CD45
 
 
 
 
 
cells.
 
Online Supplemental Material.
 
Inhibition of SCF-induced Erk
phosphorylation and Elk-1 activation by Spred-2 mutants is pre-
sented in Fig. S1. Fig. S1 and Supplemental Materials and
Methods are available at http://www.jem.org/cgi/content/full/
jem.20030830/DC1.
 
Results and Discussion
 
First, to examine any possible role that the Ras/MAP ki-
nase pathway has in AGM hematopoiesis at a midgestation
stage, we examined the effect of U0126, a MEK inhibitor,
on the appearance of CD45
 
  
 
hematopoietic lineage cells
from E11.5 primary AGM culture. In the AGM culture with
SCF, basic fibroblast growth factor (bFGF), and oncostatin
M (OSM), endothelial-like cells are initially observed and
then the nonadherent cells, which include lineage-commit-
ted cells (e.g., CD45
 
 
 
), gradually emerge (13, 14). As shown
in Fig. 1 A, U0126 dose dependently inhibited the produc-
tion of CD45
 
 
 
 
 
hematopoietic cells, whereas SB203538, a
p38 inhibitor, had no effect. Next, we tested the effect of a
dominant negative Ras (Ras-17N) and a dominant negative
mutant of Akt (K197A/T308A/S473A; Akt-DN; reference
15), which is known to function downstream of the PI3K
pathway on the generation of CD45
 
 
 
 
 
cells in the AGM cul-
ture. We used bicistronic retrovirus vector pMY-IRES-
EGFP so that the infected cells could be monitored by mea-
suring expression of an enhanced GFP by flow cytometry.
Figure 1. Role of the Ras/MAP kinase cascade in the AGM culture.
(A) E11.5 AGM cells were cultured in DMEM with 15% (vol/vol) FCS,
100 ng/ml SCF, 1 ng/ml bFGF, and 10 ng/ml OSM. On the second day
of culture, the cells were treated with various concentrations of U0126
and SB203538, respectively. After 5 d, the nonadherent cells were
counted and then the number of CD45  hematopoietic cells per well was
assessed by the percentage of CD45  cells in the nonadherent cells using
flow cytometry (n   3). (B) On the second day of the AGM culture with
the indicated cytokines, the cells were infected with mock retrovirus vector,
Ras-17N, or Akt-DN (K197A/T308A/S473A). After an additional 8 d
of culture, the nonadherent cells were stained with an anti-CD45 anti-
body and analyzed by flow cytometry (n   3). 
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As shown in Fig. 1 B, overexpression of Ras-17N reduced
the production of CD45
 
  
 
cells, whereas Akt-DN did not
strongly affect the production of CD45
 
  
 
cells in the culture
containing SCF, bFGF, and OSM (Fig. 1 B). Similar results
were observed for stimulation with SCF or bFGF alone (Fig.
1 B). These data indicate that the Ras/MAP kinase cascade
plays an essential role in AGM hematopoiesis.
Next, we attempted to define the role of Spreds in AGM
hematopoiesis. Among Spred family proteins, we focused
on Spred-2 because it has been shown to negatively regu-
late c-Kit signaling (16). We first examined Spred-2 ex-
pression in the AGM region. Hematopoietic (positive for
either CD45 or Ter119) and nonhematopoietic (negative
for both CD45 and Ter119) cells were prepared from
E11.5 AGM, and RNA from each population was sub-
jected to RT-PCR. As shown in Fig. 2 A, transcripts for
Spred-2 were detectable in both populations, whereas
those for hematopoietic transcription factor GATA-2 were
detected only in the former population. Spred-2 protein
expressed in the AGM region may play a role in the he-
matopoiesis in midgestation mouse embryo.
To examine whether the production of hematopoietic
cells in the AGM culture was regulated by Spred-2, wild-
type and truncated forms of Spred-2 and related molecules
(Fig. 2 B) were overexpressed in cultured AGM cells by ret-
rovirus gene transfer. As shown in Fig. 2 C, full-length
Spred-2 exhibited a significant inhibitory effect on the ap-
pearance of CD45
 
  
 
nonadherent cells in the AGM cultures.
In contrast, neither Sprouty-4, which is related to the Spred
proteins, nor STAP-1, which interacts with c-Kit (17), was
able to inhibit the appearance of CD45
 
  
 
cells from cultured
AGM cells (Fig. 2, C and D, and unpublished data). It has
been shown that Sprouty-4 has the inhibitory effect on
bFGF-induced Erk phosphorylation, but not epidermal
growth factor– and vascular endothelial growth factor
(VEGF)-induced Erk phosphorylation (7, 18, 19).
Next, we examined the function of each domain in the
Spred-2 protein by using deletion mutants. 
 
 
 
C could not
inhibit the production of CD45
 
  
 
cells in AGM cultures,
whereas 
 
 
 
N and 
 
 
 
KBD exhibited inhibitory effect though
the latter showed weaker effect (Fig. 2, C and D). These
results suggest that the SPR domain of Spred-2 plays a crit-
ical role in the suppression of hematopoietic cell develop-
ment in AGM cultures. We then examined the role of each
domain of Spred-2 in the SCF/c-Kit signaling pathway.
Full-length Spred-2 and 
 
 
 
N interacted with c-Kit upon
Figure 2. Inhibition of the hematopoietic differentiation by Spred-2 in cultured AGM cells. (A) Expression of Spred-2 in the AGM region. Total
RNAs were extracted from CD45  Ter119  or CD45  Ter119  cells and subjected to RT-PCR using specific primers for Spred-2, CD45, GATA-2,
and G3PDH. (B) Schematic representation of the structures of Spred-2 mutants. (C) On the second day of the AGM culture, the cells were infected with
GFP and/or a Spred-2 mutant retrovirus. After an additional 5 d of culture, the nonadherent cells were stained with an anti-CD45 antibody and analyzed
by flow cytometry. (D) The percentage of CD45  cells in the GFP  cells was determined (n   4). (E) Plat-E cells were transfected with vectors encoding
GFP-Erk-2, c-Kit, and Flag-tagged Spred-2 mutants or Sprouty-4. The cells were treated with or without 100 ng/ml SCF for 5 min. Cell lysates were
subjected to immunoprecipitation with anti-GFP antibody. Precipitates or lysates were separated by SDS-PAGE and analyzed by immunoblotting with
indicated antibody. (F) The AGM culture was infected with either mock viruses or Spred-2 viruses, and the nonadherent cells were stained with anti-
CD45 and c-Kit antibodies. In the flow cytometric analysis, only the GFP  (i.e., virus-infected) cells were analyzed for the expression of CD45 and
c-Kit. (G) Sorted populations of GFP  CD45  c-Kit , GFP  CD45low c-Kitlow/ , and GFP  CD45  c-Kit  were cultured with OP9 stromal cells in the
presence of IL-3 and SCF. 
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SCF stimulation of AGM cells. 
 
 
 
C and 
 
 
 
KBD showed
no detectable binding to c-Kit (Fig. S1 A, available at
http://www.jem.org/cgi/content/full/jem.20030830/DC1).
SCF-induced Erk phosphorylation was suppressed by
Spred-2, 
 
 
 
N, and 
 
 
 
KBD, though the suppression by the
latter two was incomplete. By contrast, 
 
 
 
C and Sprouty-4
show little or almost no inhibition of Erk activation (Fig. 2
E). Similar results were obtained by SCF-induced Elk-1 ac-
tivation in 293 cells (Fig. S1 B). These results indicated that
the COOH-terminal region of Spred-2 is required for the
interaction with c-Kit and for efficient suppression of SCF-
induced Erk-2 phosphorylation. In a previous study, we
found that the COOH-terminal region of Spred-2 or
Sprouty alone was sufficient for the suppression of Erk acti-
vation induced by VEGF in 293 cells (18). Therefore,
VEGF and SCF may have a similar activation mechanism
for MAP kinase. It is interesting to note that Spred-2•
 
 
 
N
does not inhibit Erk activation induced by epidermal
growth factor or nerve growth factor (16).
Next, we sought to examine the role of Spred-2 in the
development of hematopoietic lineage cells expressing
CD45. Nonadherent cells from the AGM culture, which
had been infected with mock viruses, were gated for GFP
expression and then analyzed for CD45 and c-Kit expres-
sion. As shown in Fig. 2 F, middle, the cells could be di-
vided into three populations: CD45
 
  
 
c-Kit
 
 
 
, CD45
 
low
 
c-Kit
 
low/
 
 
 
, and CD45  c-Kit . In Spred-2 virus–infected
AGM cells (Fig. 2 F, right), the size of the CD45low
c-Kitlow/  population was dramatically reduced (6.4-fold)
and that of the CD45  c-Kit  population was moderately
reduced (2.5-fold). To characterize the nature of the
CD45low c-Kitlow/  population, which was dramatically af-
fected by Spred-2 expression, the above mentioned three
populations of cells were cultured on the monolayer of a
stromal cell line, OP9. As shown in Fig. 2 G, only the
CD45low c-Kitlow/  population produced nonadherent he-
matopoietic cells, indicating that the CD45low c-Kitlow/ 
population could be in a more immature stage and that the
other two populations could not produce hematopoietic
cells on OP9. These results suggest that Spred-2 is a nega-
tive regulator of hematopoiesis in AGM.
To define the role of endogenous Spred-2 in hemato-
poiesis, we generated mice having Spred-2 gene mutation
by homologous recombination, in which exons encoding
the KBD and SPR domains were deleted. Offspring were
born within the Mendelian expectation ratio from inter-
crosses of heterozygotes as well as incrosses of homozy-
gotes. This indicates that Spred-2 is not necessary for fertil-
ity and development. Adult Spred-2    mice appeared to
be healthy and showed no apparent abnormalities in most
organs (unpublished data).
To examine the effect of Spred-2 deficiency on AGM
hematopoiesis at the midgestation stage, we compared the
colony-forming activity in methylcellulose of E11.5 aortic
cells from Spred-2    with that from wild-type littermates
(Fig. 3 A,    ). The number of granulocyte and macro-
phage colonies formed from Spred-2    aortic cells was sig-
nificantly higher than that from Spred-2 /  littermate aor-
tic cells, indicating that Spred-2 has an inhibitory effect on
colony-forming potential of hematopoietic progenitors.
Figure 3. Induction of AGM hematopoietic differentiation in Spred-2   
cells. (A) Colony-forming activities in primary E11.5 aorta cells in Spred-2–
deficient mice. Primary E11.5 aorta cells from Spred-2 /  and Spred-2   
littermates were inoculated in methylcellulose media containing 100 ng/ml
SCF, 20 ng/ml IL-3, and 4 U/ml EPO. Colonies were scored after 7 d of
culture (n   4). Colony types: G, granulocytes; M, macrophages; GM,
granulocytes and macrophages; E, erythrocytes; Mix, granulocytes, macro-
phages, and erythrocytes. (B) Expansion of nonadherent cells from the
Spred-2    AGM culture. E11.5 AGM cells from Spred-2    and Spred-2   
littermates were plated on gelatin-coated 24-well plates at a density of
1.5   105 per well with cytokines as described above. On the seventh day
of culture, the nonadherent cells generated were counted. (C) The num-
bers of CD45  nonadherent cells per well were determined by the percent-
age of CD45  cells in the nonadherent cells (n   3). (D) 2   103 sorted
VE-cad  cells from E10.5 Spred-2    or Spred-2    littermates were cul-
tured on OP9 stromal cells in the presence of IL-3, SCF, and EPO. The
number of cobble stone areas was counted by phase contrast microscopy
(n   3). (E) 5   103 sorted VE-cad  cells from Spred-2 /  or Spred-2   
littermates were inoculated in the methylcellulose medium as described
above. The number of colonies was scored after 7 d of culture (n   3).Nobuhisa et al. Brief Definitive Report 741
Next, we examined the effect of Spred-2 deficiency on
embryonic hematopoiesis using the AGM culture. As
shown in Fig. 3 B, the number of nonadherent cells pro-
duced in the culture of AGM from Spred-2    was greater
than that from Spred-2 /  littermates, and the ability of the
AGM region of Spred-2    to generate CD45  hematopoi-
etic cells in this culture was threefold higher than that of
Spred-2 /  (Fig. 3 C). These results indicate that loss of
Spred-2 function leads to an increase in hematopoiesis in
the AGM region of midgestation mouse.
It has been reported that hematopoietic cells develop
from VE-cad  cells (20). When VE-cad  cells in E10.5 em-
bryo were cultured on a monolayer of OP9 stromal cells,
we observed cobble stone area–forming cells, which are
suggested to produce HSCs (21). The number of cobble
stone areas found in the cultured VE-cad  cells from E10.5
Spred-2    embryo was 2.2-fold larger than that from wild-
type littermates (Fig. 3 D,    ). Colony-forming ability of
VE-cad  cells sorted from E10.5 Spred-2    and Spred-2 / 
littermates was assayed in methylcellulose media. As shown
in Fig. 3 E, VE-cad  cells from Spred-2    formed a 3.6-
fold larger number of colonies. These results suggest that
Spred-2 negatively regulates hematopoiesis in AGM.
Finally, we examined whether a deficiency of Spred-2
causes hematopoietic abnormality in adult mice. As shown
in Fig. 4 A, marked increase in the number of megakaryo-
cytes was observed in the spleen of Spred-2–deficient mice,
although no qualitative or quantitative abnormalities in pe-
ripheral blood hematopoietic cells were observed. Colony-
forming assay of adult bone marrow cells in methylcellulose
revealed that approximately twofold more hematopoietic
cell colonies were produced from bone marrow cells of
Spred-2    mice (381.9   33.1 colonies/3   104 cells) as
compared with those from wild-type littermates (250.7  
18.9 colonies/3   104 cells; Fig. 4 B). These data suggest
that Spred-2 is at least in part involved in the regulation of
hematopoiesis in vivo.
In this study, Spred-2–deficient mice displayed an en-
hanced ability of their AGM cells to differentiate into he-
matopoietic cells at ontogeny. The phenotype in Spred-2–
deficient mice resembles that in Lnk-deficient mice whose
E11.5 AGM exhibited more potent capacity of hematopoi-
etic differentiation in the culture and in the colony-form-
ing assay (11). It has been reported that a stable transfor-
mant of mast cell line MC9 with Lnk cDNA showed a
marked attenuation of the SCF-mediated phosphorylation
of Gab-2 and the subsequent phosphorylation of Erk-1/2
using the mast cell line MC9 (22). Thus, these proteins
having a negative effect on the Ras/MAP kinase cascade
demonstrate inhibitory activity on AGM hematopoiesis.
On the other hand, Spred-2 deficiency caused a significant
increase in the number of megakaryocytes in the adult
spleen (Fig. 4 A). This phenotype is very similar to that ob-
served in mice with homozygous deletion of Lnk (23). It
should be noted that the maturation of progenitor cells to
megakaryocytes is induced by activation of Erk MAP ki-
nase, which is consistent with our finding (24, 25). There-
fore, elevation of megakaryopoiesis in the spleen of Spred-
2    mice supports our idea that Spred-2 is a negative regu-
lator of the Ras/MAP kinase pathway in hematopoiesis.
In conclusion, here we have shown that Spred-2 plays
an inhibitory role in AGM hematopoiesis. Our results
suggest that Spred-2 has negative effects on differentiation
of vascular endothelial cells into hematopoietic cells (Fig.
3, D and E). To further support our idea, time lapse anal-
ysis or single cell fate analysis of VE-cad  cells may need
to be undertaken.
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